INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $22,208,000 | -46.2% | 22,244,000 | -44.7% | 0.02% | -38.2% |
Q4 2021 | $41,259,000 | +43.1% | 40,244,000 | +43.9% | 0.03% | +30.8% |
Q3 2021 | $28,840,000 | +1003.7% | 27,975,000 | +1030.3% | 0.03% | +1200.0% |
Q2 2021 | $2,613,000 | -6.5% | 2,475,000 | -1.0% | 0.00% | -33.3% |
Q1 2021 | $2,796,000 | – | 2,500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sycale Advisors (NY) LLC | 8,065,000 | $9,173,000 | 6.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $69,219,000 | 1.37% |
Sonora Investment Management, LLC | 6,645,000 | $7,519,000 | 0.62% |
ZAZOVE ASSOCIATES LLC | 4,377,000 | $4,951,000 | 0.61% |
ADVENT CAPITAL MANAGEMENT /DE/ | 22,362,000 | $25,324,000 | 0.54% |
SSI INVESTMENT MANAGEMENT LLC | 6,532,000 | $7,328,000 | 0.52% |
Context Capital Management, LLC | 2,163,000 | $2,438,000 | 0.33% |
WOLVERINE ASSET MANAGEMENT LLC | 35,070,000 | $39,493,000 | 0.29% |
Cheyne Capital Management (UK) LLP | 450,000 | $509,000 | 0.26% |
FARALLON CAPITAL MANAGEMENT LLC | 32,500,000 | $36,552,000 | 0.22% |